Oklahoma Healthcare Wire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oklahoma Healthcare Wire.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on March 20, 2026

Mar. 20, 2026

Publication relating to transparency notifications

GlobeNewswire

Mar. 20, 2026

Publication relative à des notifications de transparence

GlobeNewswire

Mar. 20, 2026

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 20, 2026

Garaherb Claims Evaluated: Complete Scientific Investigation of Ingredients' Effectiveness

GlobeNewswire

Mar. 20, 2026

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 20, 2026

Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 20, 2026

XTL Biopharmaceuticals Announces ADS Ratio Change

GlobeNewswire

Mar. 20, 2026

argenx announces Annual General Meeting of Shareholders on May 6, 2026

GlobeNewswire

Mar. 20, 2026

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

Mar. 20, 2026

Akemi Detox Tea Claims Evaluated: Investigating Natural Ingredients to Burn Fat and Boost Energy Support

GlobeNewswire

Mar. 20, 2026

Purisaki Deep Cleansing Foot Pads Claims Evaluated: The 2-in-1 MultiVitamin Detox Patch for Therapeutic Support

GlobeNewswire

Mar. 20, 2026

ReflexMD GLP-1 Claims Evaluated: Safety Risks Assessed for Reflex MD Semaglutide Telemedicine Provider

GlobeNewswire

Mar. 20, 2026

Trim RX GLP-1 Weight Loss Medication Claims Evaluated: Investigating the TrimRX Treatment Options

GlobeNewswire

Mar. 20, 2026

Sanuwave Will Host a Conference Call on March 27, 2026 at 8:30 AM (ET) to Present Q4 and Full Year 2025 Financial Results

GlobeNewswire

Mar. 20, 2026

SafeSpace Global Corporation Reports Q2 Fiscal 2026 Financial Results; Company Transitions from Pre-Revenue to Revenue-Generating Stage, Expands Footprint with Nashville Office, and Initiates Steps Toward National Exchange Uplisting

GlobeNewswire

Mar. 20, 2026

Results from Real-World, Long-Term Treatment Persistence with LEQEMBI® (lecanemab-irmb) in the United States Presented at AD/PD™ 2026

GlobeNewswire

Mar. 20, 2026

Aclaris Therapeutics Announces Poster on Results from Phase 2a Trial of ATI-2138 at the 2026 American Academy of Dermatology (AAD) Annual Meeting

GlobeNewswire

Mar. 20, 2026

Longeviti Neuro Solutions Appoints T. Rowe Price CEO Robert W. Sharps to Board of Directors

GlobeNewswire

Mar. 20, 2026

BIOXYTRAN, INC. COMPLETES $1.2 MILLION PRIVATE PLACEMENT

GlobeNewswire

Mar. 20, 2026

RenovoRx to Host Fourth Quarter and Full Year 2025 Financial Results and Business Highlights Conference Call on March 30th at 4:30 p.m. ET

GlobeNewswire